Work

Author Correction: Jawsamycin exhibits in vivo antifungal properties by inhibiting Spt14/Gpi3-mediated biosynthesis of glycosylphosphatidylinositol

Year: 2020

Type: erratum

Source: Nature Communications

DOI: 10.1038/s41467-020-17748-7

Authors: Yue Fu, David Estoppey, Silvio Roggo, Dominik Pistorius, Florian Fuchs, Christian Studer, Ashraf S. Ibrahim, Thomas Aust, Frederic Grandjean, Manuel Mihalic, Klaus Memmert, Vivian Prindle, Etienne Richard, Ralph Riedl, Sven Schuierer, Eric Weber, Jürg Hunziker, Frank Petersen, Jianshi Tao, Dominic Hoepfner

Institutions: Genomics Institute of the Novartis Research Foundation, Novartis (Switzerland), Novartis Institutes for BioMedical Research, University of California, Los Angeles, The Lundquist Institute, UCLA Medical Center, Harbor–UCLA Medical Center

Language: English

Topic: Antifungal resistance and susceptibility

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

Open Access status: gold

Estimated APC paid: $5,380

Funder: National Institute of Allergy and Infectious Diseases

Award: Novel Toxins and Receptors in Mucormycosis Pathogenesis and Treatment

OpenAlex ID: W3046843364

Cites:

Cited by: 3

Related to: 10